CAS: 1463510-35-1
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 1-[4-[4-Morpholin-4-yl-6-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]phenyl]-3-pyridin-4-ylurea, hydrochloride REF: 3D-NIC51035CAS: 1463510-35-1 | Min. 95% | A consultar | Ter 26 Nov 24 |
 | PKI-179 hydrochloride REF: TM-T36085CAS: 1463510-35-1 | - - - | 700,00 €~1.468,00 € | Ter 03 Dez 24 |
![1-[4-[4-Morpholin-4-yl-6-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]phenyl]-3-pyridi…](https://static.cymitquimica.com/products/3D/thumb/NIC51035.jpg)
1-[4-[4-Morpholin-4-yl-6-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]phenyl]-3-pyridin-4-ylurea, hydrochloride
CAS:1463510-35-1
1-[4-[4-Morpholin-4-yl-6-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]phenyl]-3-pyridin-4-ylurea is a peptide inhibitor that binds to the ATP binding site of protein kinase …
Fórmula:
C25H29ClN8O3
Pureza:
Min. 95%
Peso molecular:
525 g/mol
Ref: 3D-NIC51035
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 26 de Novembro de 2024
PKI-179 hydrochloride
CAS:1463510-35-1
PKI-179: oral PI3K/mTOR inhibitor; IC50: PI3Kα/β/δ/γ (8-74 nM), PI3Kα mutants (11-14 nM), mTOR (0.42 nM); …
Fórmula:
C25H29ClN8O3
Cor e Forma:
Solid
Peso molecular:
525
Ref: TM-T36085
| 25mg | 700,00 € | ||
| 50mg | 909,00 € | ||
| 100mg | 1.468,00 € |
Entrega estimada em Estados Unidos, Terça-feira 3 de Dezembro de 2024
